GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 34 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 146 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | – | 146 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 146 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 146 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 146 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | – | 146 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 146 | -94.0% | 0.00% | – |
| Q4 2021 | $15,000 | -77.3% | 2,453 | -48.5% | 0.00% | – |
| Q3 2021 | $66,000 | – | 4,764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|